Sudarshan Chemical Industries Limited — Board Meeting, 25-07-2025: Outcome of Board Meeting

Sudarshan Chemical's board approved its Q4 and full-year FY25 consolidated results. FY25 consolidated revenue hit ₹3,345.58 Cr, with PAT at ₹357.45 Cr. Q4 revenue was ₹1,349.44 Cr, PAT ₹55.75 Cr.

Key strategic move: acquisition of Heubach Group's global pigment business for ~₹1,390 Cr. Funded by over ₹995 Cr via QIP, preferential issue & warrants, this deal drove a significant one-time gain.

Board proposed ₹4.5/share dividend for FY25. Mr. Rajesh Rathi is now Chairman & MD. Also, approved a €25M corporate guarantee for subsidiary FX hedging.